- Previous Close
0.0458 - Open
0.0458 - Bid 0.0458 x --
- Ask 0.0500 x --
- Day's Range
0.0458 - 0.0458 - 52 Week Range
0.0250 - 0.2200 - Volume
2 - Avg. Volume
41,081 - Market Cap (intraday)
1.436M - Beta (5Y Monthly) -0.13
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1800 - Earnings Date Mar 31, 2025 - Apr 4, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
www.acutusmedical.comRecent News: AFIB
View More
Performance Overview: AFIB
Trailing total returns as of 3/24/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AFIB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AFIB
View MoreValuation Measures
Market Cap
1.42M
Enterprise Value
24.61M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.09
Price/Book (mrq)
--
Enterprise Value/Revenue
1.60
Enterprise Value/EBITDA
16.65
Financial Highlights
Profitability and Income Statement
Profit Margin
-272.56%
Return on Assets (ttm)
-14.20%
Return on Equity (ttm)
-49.22%
Revenue (ttm)
15.38M
Net Income Avi to Common (ttm)
-5.27M
Diluted EPS (ttm)
-0.1800
Balance Sheet and Cash Flow
Total Cash (mrq)
12.6M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
4.71M
Research Analysis: AFIB
View MoreCompany Insights: AFIB
AFIB does not have Company Insights